| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2256 |
| Trial ID | NCT04173988 |
| Disease | Childhood B-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | AlloCAR-T-19 |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia |
| Year | 2020 |
| Country | China |
| Company sponsor | Children's Hospital of Fudan University |
| Other ID(s) | 2019-272 |
| Cohort 1 | |||||||||||||
|
|||||||||||||